WESTFIELD CAPITAL MANAGEMENT CO LP 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 09:15 am Purchase | 2024-12-31 | 13G | Ascendis Pharma A/S ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 5,528,239 9.180% | 1,453,025 (+35.66%) | Filing |
| 2025-02-10 5:13 pm Purchase | 2024-12-31 | 13G | Ascendis Pharma A/S ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,075,214 9.180% | 44,580 (+1.11%) | Filing |
| 2024-02-02 1:18 pm Purchase | 2023-12-29 | 13G | Ascendis Pharma A/S ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,030,634 7.050% | 872,466 (+27.63%) | Filing |
| 2023-02-01 7:36 pm Purchase | 2022-12-30 | 13G | Ascendis Pharma A/S ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 3,158,168 5.540% | 3,158,168 (New Position) | Filing |